Contact Us

Health Care Reform, Device Tax

What is the medical device tax?

The $20B tax was included in the Affordable Care Act that was signed into law in 2010. The amount is based on a 2.3% excise tax that will be levied on the total revenues of a company, regardless of whether a company generates a profit, starting in 2013. Many companies will owe more in taxes than they generate from their operations. The result will be devastating to innovation, patient care and job creation.

 

What is MDMA’s position?

MDMA was against the medical device tax from the beginning, and continues to work for a full repeal of this onerous provision. The overwhelming majority of innovation from the medical device industry comes from smaller manufacturers who work closely with clinicians and engineers to develop the therapies and treatments of tomorrow. If it is not repealed, this tax will stifle innovation, harm patient care and weaken the position of the United States as the global leader in medical device innovation.

MDMA has pointed out that there is no data or studies that show the costs of this "innovation tax" will be offset due to an increased pool of insured beneficiaries receiving treatment. In fact, since the majority of products impacted are used in acute care settings where there are legal obligations to treat a patient, the effect of expanded coverage is not likely to increase utilization.

MDMA continues to work with elected officials and our members on the bipartisan proposals to eliminate the medical device tax to ensure that patient care, innovation and job creation continue to thrive.
04/08/2011

WASHINGTON, DC -- The Medical Device Manufacturers Association (MDMA) reiterated their belief that payments to group purchasing organizations (GPOs) should be subjected to “sunshine” provisions to increase transparency and competition in the delivery of healthcare.  MDMA issued preliminary comments to the Centers for Medicare and Medicaid Services (CMS) following the “Special Open Door Forum: Transparency Reports and Reporting of Physician Ownership or Investment Interests” that...

03/31/2011

WASHINGTON, DC -- Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), today issued the following statement in response to the proposed regulation for Accountable Care Organizations (ACOs):

“MDMA remains firmly committed to ensuring that patients have timely access to safe and effective products and that nothing compromises the physician-patient relationship.  As we have stated in the past, MDMA opposes any...

03/23/2011

WASHINGTON, DC – On the one year anniversary of the 2.3% medical device excise tax that was signed into law as a part of The Affordable Care Act, the Medical Device Manufacturers Association (MDMA) today reiterated their commitment to repealing the tax so that innovation and job creation can thrive.

“MDMA and its members strongly believe that the device tax included in health care reform will harm patient care and thwart innovation and job creation at a time...

01/25/2011

WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA) issued the following statement today regarding the introduction of legislation in Congress to repeal the medical device tax:

“We applaud Senator Orrin Hatch and Congressman Erik Paulsen for their leadership and recognition of just how critical the medical technology industry is to the economic engine in America,  and we urge Republicans and Democrats to come together to...

09/01/2010
Associated Press

BOSTON (AP) -- Medical device manufacturers are bristling over a key provision in the nation's new health care law which they say forces them to shoulder an unfair cost of expanded insurance coverage.

A 2.3 percent excise tax on companies that supply medical devices like heart defibrillators and surgical tools to hospitals, health centers and ambulance services will cost medical device manufacturers an estimated $20 billion in new taxes over the next decade. And they say that will...

06/30/2010

Legislation was introduced this week to repeal the medical device tax and offset its costs by using unspent stimulus funds. The legislation, introduced by Congressman Brian Bilbray (CA-50), recognizes the important role medical device manufacturers play in improving patient care and driving innovation.

Congressman Bilbray’s legislation is the second bill introduced in the U.S...

03/21/2010

The House of Representative's passed the Senate health care reform bill by a vote of 219-212.  In addition, the House also passed a corresponding reconciliation bill by a vote of 220-211.  The President is expected to sign the initial Senate bill into law on Tuesday. The Senate will likely take up the reconciliation bill on Wednesday and try to pass it before Easter.
 
MDMA is very concerned about the impact a $20B device tax will have on patient care, innovation and...

02/25/2010

Today, the President met with Democrat and Republican leadership to discuss a bipartisan way forward on health care reform. Based on the discussions, common ground was established in some areas, but deep divisions remain in other areas. For example, Republicans Jon Kyl (R-AZ) and Eric Cantor (R-VA) raised concerns about taxing medical device companies. MDMA remains committed to a bipartisan health care reform bill, but strongly opposes proposals that would levy $20B tax on medical device...

01/28/2010

As President Obama delivered his State of the Union address this week, Congressional Democrats continue to examine options on moving health care reform legislation forward. Democrats discussed the possibility of the House of Representatives passing the Senate bill passed in December. If the House voted affirmatively on the Senate bill, then the legislation would then go to the President for his approval. However, many in the House have already discounted this proposal, signaling that the...